X4 Pharmaceuticals (XFOR) Profit Metrics
Price: $5.07
Market Cap: $29.35M
Avg Volume: 92.87K
Market Cap: $29.35M
Avg Volume: 92.87K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Profit Metrics Summary (Annual)
According to X4 Pharmaceuticals's latest annual financial reports:
- The company has reported a gross profit of 1.76M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 68.83%, with a year-over-year growth of 188.18%.
- X4 Pharmaceuticals's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -27.58M. The EBITDA margin stands at -1078.45%, showing a growth of 74.25% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -36.40M. The operating margin is -1423.58%, with a year-over-year growth of 66.15%.
- The net income, which shows the company's total earnings or profit after all expenses, is -37.45M. The net profit margin is -1464.61%, demonstrating a growth of 62.98% from the previous year.
These metrics provide a comprehensive overview of X4 Pharmaceuticals's profitability and operational efficiency over the past year.
Gross Profit
$1.76M
Gross Profit Margin (2023)
68.83%
EBITDA
$-27.58M
EBITDA Margin
-1078.45%
Operating Income (2023)
$-36.40M
Operating Margin
-1423.58%
Net Income
$-37.45M
Net Profit Margin
-1464.61%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
X4 Pharmaceuticals Historical Profit Metrics
X4 Pharmaceuticals Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $1.76M | 188.18% | $-36.40M | 66.15% | $-37.45M | 62.98% | $-27.58M | 74.25% |
| 2023 | $-2.00M | -0.10% | $-107.52M | -22.79% | $-101.17M | -7.78% | $-107.10M | -22.31% |
| 2022 | $-1.99M | -5.39% | $-87.57M | -2.89% | $-93.87M | -5.83% | $-87.57M | -2.89% |
| 2021 | $-1.89M | -163.07% | $-85.11M | -42.14% | $-88.70M | -42.76% | $-85.11M | -46.57% |
| 2020 | $3.00M | 546.43% | $-59.87M | -15.80% | $-62.13M | -9.76% | $-58.06M | -12.30% |
| 2019 | $-672.00K | -119.78% | $-51.70M | -12.68% | $-56.60M | -31.57% | $-51.70M | -12.68% |
| 2018 | $3.40M | 1842.05% | $-45.88M | -26.99% | $-43.02M | -26.99% | $-45.88M | -45.19% |
| 2017 | $-195.00K | 35.00% | $-36.13M | -48.41% | $-33.88M | -47.45% | $-31.60M | -56.76% |
| 2016 | $-300.00K | 25.00% | $-24.35M | -64.22% | $-22.98M | -73.82% | $-20.16M | -63.29% |
| 2015 | $-400.00K | 0.00% | $-14.82M | 0.00% | $-13.22M | 0.00% | $-12.35M | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for XFOR.